Galectin Therapeutics Inc.GALTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank20
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-30.17M
↓ 14% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-26.54M
Historical baseline
PeriodValueYoY Change
TTM$-30.17M+27.3%
2024$-41.47M-8.4%
2023$-38.24M-1.4%
2022$-37.71M-25.7%
2021$-30.00M-28.5%
2020$-23.34M-77.2%
2019$-13.17M+2.9%
2018$-13.56M+16.4%
2017$-16.23M+24.4%
2016$-21.47M-